Equity
Venture Debt Warrants: What 10% Coverage Costs in Dilution, Interest, and Your 409A
Warrant coverage is a slice of your loan, not your company. What a venture debt warrant is worth, what it adds to your interest, and what it does to your 409A.
By 409.AI Team - 2026-08-28
# Venture Debt Warrants: What 10% Coverage Costs in Dilution, Interest, and Your 409A
A term sheet for a venture loan looks refreshingly simple next to a priced round. One page of economics, a rate, a term, a few covenants, and one line near the bottom: *10% warrant coverage*. Founders sign it because it reads like a rounding error compared to selling 20% of the company.
Then the auditors ask how the warrant was valued, the interest expense comes in higher than the stated rate, and the next 409A shows up with an extra line in the cap table.
Venture debt is not a niche product anymore. The Q1 2026 [PitchBook-NVCA Venture Monitor](https://nvca.org/pitchbook-nvca-venture-monitor/) put the median US venture debt deal at $10.8 million and the average at $68.2 million, with growth-stage companies taking 67% of all venture debt dollars, about $13.3 billion in the quarter. More companies are borrowing, which means more cap tables are carrying lender warrants. So it is worth knowing what one actually costs.
Warrant coverage is not dilution
This trips up almost everyone the first time. Warrant coverage is a percentage of the loan amount, not a percentage of your company.
Say you draw an $8 million facility with 10% warrant coverage. The lender gets warrants to buy $800,000 worth of stock, usually at the price of your most recent preferred round. If that round priced Series B at $4.00 a share, the lender holds a warrant over 200,000 shares.
On a fully diluted base of 22 million shares, those 200,000 shares are about 0.9% of the company. So 10% coverage translates into under 1% dilution. That is the whole trick of the number, and it is why coverage figures that sound enormous usually are not.
What matters more than the headline percentage is the reference price. A warrant struck at your last round price is cheap for the lender if the next round is a big step up. A warrant struck at the *next* round's price, which some lenders push for, is a blank check on your future valuation. Fight harder over that line than over a point or two of coverage.
What the warrant is worth on day one
A warrant is a long-dated call option, and it gets valued like one. Seven and ten-year terms are both common, and at that length the option value is a large fraction of the underlying share price even when the strike sits at the money.
Run the $4.00 Series B example through Black-Scholes with a 10-year term, 55% volatility drawn from guideline public companies, a 4% risk-free rate, and no dividends. The warrant comes out around $2.76 per share, roughly 69% of the underlying price. Across 200,000 shares that is about $551,000.
Private shares are not freely tradable, so a valuation specialist will usually apply a marketability adjustment, the same [discount for lack of marketability](https://409.ai/articles/discount-lack-marketability-dlom-409a-valuation) that shows up in your 409A. Take 20% off and the warrant is worth roughly $440,000 at issuance.
Stop and look at that number. The lender did not pay you $440,000 for it. You handed it over as part of the price of the loan, on top of the interest. Long option terms are what make lender warrants expensive, which is why a five-year or seven-year term is worth negotiating even when the coverage percentage is fixed.
Your loan is more expensive than the rate says
Here is where the warrant stops being a cap table question and becomes an income statement question.
When a company issues debt with detachable warrants, ASC 470-20 requires the proceeds to be split between the two instruments based on their relative fair values at issuance. Your $8 million loan and a $440,000 warrant are two separate things you sold for a single price, and the accounting insists on pricing them separately.
Assume the loan alone would have been worth its $8 million face value on market terms. Relative fair values are $8.0 million and $0.44 million, so about $7.58 million of the proceeds is attributed to the debt and roughly $420,000 to the warrant. The debt was recorded at a $420,000 discount, and that discount gets amortized to interest expense over the three-year term.
Call it $139,000 a year of extra interest on top of the coupon. At a stated 10.5% rate you were budgeting $840,000 of annual interest, and your financial statements will show closer to $979,000, or roughly 12% of the face amount. The cash rate on the term sheet and the cost of capital in your books are not the same number, and your finance lead should model the second one before the loan closes.
The classification question comes next. Most straightforward lender warrants over common stock sit in equity, but a warrant can land in liabilities under ASC 480 or ASC 815-40 if it is settleable in cash, tied to redeemable shares, or otherwise fails the conditions for being indexed to the company's own stock. A liability-classified warrant is remeasured at fair value every reporting period, so every increase in your share price runs through earnings as a loss. Companies that grow fast get punished on paper for it. Ask your auditor to review the warrant form before signing, not after year end.
One thing lender warrants are *not*: stock compensation. ASC 718 covers share-based payments made to acquire goods or services, which is why it governs [employee option expense](https://409.ai/articles/asc-718-stock-based-compensation-startup-guide) and why a different standard governs [warrants issued to a customer](https://409.ai/articles/customer-warrants-asu-2025-04-share-based-consideration). A warrant handed to a lender is a cost of financing, so it lives with the debt, not in your comp expense.
If your warrant carries down round protection, note that ASU 2017-11 changed how that feature is treated: a down round feature alone no longer prevents equity classification. When the reset is actually triggered, though, the value of that adjustment is treated as a deemed dividend that reduces income available to common shareholders.
The tax treatment runs on a separate track
Tax law reaches the same destination by a different road. A note issued together with a warrant is an investment unit under [IRC Section 1273(c)(2)](https://www.law.cornell.edu/uscode/text/26/1273), and [Treasury Regulation Section 1.1273-2(h)](https://www.law.cornell.edu/cfr/text/26/1.1273-2) requires the issue price of the unit to be allocated between the debt and the warrant based on their relative fair values.
Because part of the price is assigned to the warrant, the debt's issue price falls below what you have to repay at maturity. The difference is original issue discount, which you accrue as interest for tax purposes over the life of the loan rather than deducting all at once.
The allocation percentages for tax and for GAAP are driven by the same relative fair values, but they are separate computations with their own rules, and the deductibility of the resulting interest depends on limits that apply to your company. Get your tax advisor to run the OID schedule when the loan closes. Reconstructing it two years later from a term sheet and a bank statement is a bad afternoon.
For the lender, the shares are not acquired until the warrant is exercised. That timing matters if anyone is counting on Section 1202: stock has to be acquired at original issue for [QSBS](https://www.law.cornell.edu/uscode/text/26/1202) purposes, and the five-year clock on shares issued through a warrant exercise starts at exercise, not at the date the warrant was granted. It is the same clock problem that catches holders of [SAFEs waiting on conversion](https://409.ai/articles/safes-qsbs-holding-period-conversion-section-1202).
What it does to your next 409A
A lender warrant changes your capital structure, so it changes the valuation that sets your employees' strike price.
Two effects show up. First, the warrant shares join the fully diluted count, which spreads equity value across a slightly larger base. Second, and more meaningfully, an [option pricing model](https://409.ai/articles/409a-allocation-methods-opm-pwerm-backsolve) treats the warrant as its own claim on equity value, exercisable at its own strike. Above that strike, the warrant takes a slice of upside that would otherwise belong to common. Below it, the warrant is worthless and common is unaffected.
Whether the warrant is over common or over preferred matters more than founders expect. A warrant over Series B preferred, once exercised, carries the Series B liquidation preference with it, so it sits ahead of common in the [exit waterfall](https://409.ai/articles/liquidation-preferences-waterfall-common-stock-exit) rather than beside it. Preferred warrants push more value away from common than common warrants do.
The direction of the effect is familiar if you have watched [convertible notes move a 409A](https://409.ai/articles/convertible-notes-effect-on-409a-valuation) or seen [how SAFEs shift the strike price](https://409.ai/articles/how-safes-affect-your-409a-valuation). An instrument that is not stock today still gets modeled as a claim on tomorrow's equity value. In practice a sub-1% warrant moves the common price per share by a small amount, but the appraiser has to see the warrant to model it, and warrants are the single most commonly forgotten item in the documents companies send over. They live in loan files, not in the cap table software.
Tell your valuation provider about every outstanding warrant, including any left over from a facility you have already repaid, since most lender warrants survive the loan they came with. Send the actual warrant agreement rather than a summary. The strike, the term, the share class, and the anti-dilution language all change the model.
Before you sign
Five things are usually negotiable even when the rate is not: the term of the warrant, the share class it covers, whether the strike references the last round or the next one, whether a net exercise is permitted, and whether the warrant terminates on an IPO or an acquisition. Each of those changes what the warrant is worth, which changes your debt discount, which changes the effective interest rate you will report.
The number worth carrying out of this: a 10% warrant on an $8 million loan costs under 1% of the company, roughly $420,000 of extra interest expense across a three-year term, and one more claim your appraiser has to model. That is a fair price for capital you did not have to raise a round to get, but only if you price it before you sign rather than after your auditor does.
If you are taking on venture debt this year, a current [409A valuation](https://409.ai/products/409a) that reflects the warrant, and [ASC 718 support](https://409.ai/products/asc-718) that keeps your equity expense consistent with it, will save you the cleanup later.